Brief: Bergenbio ASA Says Board Considering Sale, Merger, Or Other Strategic Deal
03/06/2025 18:23
June 3 (Reuters) - Bergenbio ASA BGBIO.OL: BERGENBIO ASA: UPDATE ON STRATEGIC REVIEW PROCESS AND STATUS OF ACTIVITIES BERGENBIO ASA - BOARD CONSIDERING SALE, MERGER, OR OTHER STRATEGIC DEAL BERGENBIO ASA - TO DISCONTINUE ALL REMAINING BEMCENTINIB ACTIVITIES BERGENBIO ASA - FREE CASH AFTER CLOSURE ESTIMATED AT NOK 40-45 MILLION BERGENBIO ASA - TO DISCONTINUE ALL REMAINING DEVELOPMENT ACTIVITIES FOR BEMCENTINIB Source text: ID:nWkrXCSxx Further company coverage: BGBIO.OL ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Oncoinvent ASA
See all newsBrief: Oncoinvent To Raise Up To NOK 140 Million In Private Placement
Brief: Oncoinvent H1 Operating Loss NOK 69 Mln
Brief: Oncoinvent Secures New Patent Expanding Protection For Radspherin
Brief: Oncoinvent's Shares To Be Consolidated In Ratio Of 100:1
Brief: Oncoinvent To Increase Share Capital In Connection With Settlement Of Underwriting Fee